US FDA consults on using patient experience to support approval of novel devices
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is inviting feedback on a draft guideline that explains how the "experience and perspectives of patients" with certain medical devices can be used to support the approval of such products1,2.
You may also be interested in...
Final Guidance Encourages Use Of Patient Preference In Device Applications
US FDA released a final guidance aimed at helping sponsors and other stakeholders interested in using patient-preference information to make their case for a device application. The agency has decided to keep its labeling recommendation in the final guidance despite industry objections.
EU Group Facilitates Switching Multinational Trials To CTR
Revisions to the updated EU guideline on transitioning multinational trials to the Clinical Trials Regulation are said to be “solution oriented.”
EMA Addresses Rapid Acting Therapies, Psychedelics In Updated Guidance On Depression Treatments
The European Medicines Agency is consulting on major changes to its decade-old guidance on the development of medicinal products for acute and long-term treatment of major depressive disorder.